Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(−)-(α)-Kainic acid is a cyclic analog of L-glutamate originally isolated from D. simplex that has neuroexcitatory activities.1 It binds to the homomeric kainate receptors GluK1, GluK2, GluK3, GluK4, and GluK5 (Kis = 75.9, 12.7, 32.8, 4.7, and 15 nM, respectively).2 (−)-(α)-Kainic acid (5 mM) induces calcium influx and membrane depolarization, as well as glutamate release, in rat brain synaptosomes.3 It induces chromatin condensation and nuclear membrane fragmentation, markers of apoptosis, in primary neonatal cerebellar granule neurons when used at a concentration of 100 µM.4 Intracerebroventricular administration of (−)-(α)-kainic acid induces convulsive behavior in rats (ED50 = 0.51 nmol/animal) and induces seizures in mice with a 50% convulsive dose (CD50) value of 0.39 nmol/animal.5 It has been commonly used to induce seizures in rodents.6,7
WARNING This product is not for human or veterinary use.
1. Total synthesis of (−)-
2. Chemo-
3. Effects of kainic acid in rat brain synaptosomes: The involvement of calcium. J. Neurochem. 43(3), 747-754 (1984).
4. Kainic acid induces apoptosis in neurons. Neuroscience 75(4), 1047-1055 (1996).
5. Domoic acid toxicity in rats and mice after intracerebroventricular administration: Comparison with excitatory amino acid agonists. Pharmacol. Toxicol. 70(2), 115-120 (1992).
6. Kainic acid-
7. Neuroprotective potential of mGluR5 antagonist MTEP: Effects on kainate-